血清干扰素α-2a水平与系统性硬化症疾病严重程度及预后的关联
研究检测200例系统性硬化症(SSc)患者和29名健康对照的血清IFN-α2a浓度,分析其与细胞因子/趋化因子及临床表型的关联。以15.9 fg/ml为界定义I型IFN特征,该特征与趋化因子升高及基线的皮肤和间质性肺病(ILD)受累相关,但纵向数据未发现IFN能预测ILD进展。
要点
- SSc患者血清IFN-α2a均值49.20±156.8 fg/ml,健康对照9.606±4.399 fg/ml,差异未达统计学显著(P=0.158)。
- 以15.9 fg/ml为界,62例患者存在循环I型IFN特征,其CCL8、CCL19、CXCL10、CXCL11及IL-1α水平显著高于无该特征者。
- IFN-α2a浓度与I型IFN相关趋化因子评分强相关,且与基线皮肤和ILD受累相关,但纵向数据未显示其可预测ILD进展。
核心结论
- 血清检测显示I型IFN通路激活与炎症介质强相关,并与SSc患者的皮肤纤维化和ILD等临床表现相关,但活化的IFN通路不能预测ILD进展。
研究设计与样本
- 研究纳入200例SSc患者和29名健康对照,采用超敏电化学发光法测定血清IFN-α2a,用Luminex® Discovery Assay多因子试剂盒检测炎症和趋化因子面板,记录基线疾病特征并纵向随访2年以判定ILD进展。
主要发现
- SSc患者IFN-α2a浓度为49.20±156.8 fg/ml,健康对照为9.606±4.399 fg/ml,两组差异未达统计学显著(P=0.158)。
- 以15.9 fg/ml为界,62例患者被判定为循环中存在I型IFN特征。
- 有IFN特征的患者CCL8、CCL19、CXCL10、CXCL11及IL-1α水平显著高于无IFN特征者。
- IFN-α2a浓度与I型IFN相关趋化因子评分强相关。
- 表型关联分析显示IFN值与基线皮肤和ILD受累相关,纵向数据未将IFN识别为ILD进展的预测标志物。
关键数值与推荐
- 血清IFN-α2a以15.9 fg/ml为cut-off界定I型IFN特征,共识别62例有该特征的患者。
- 有IFN特征者CCL8、CCL19、CXCL10、CXCL11及IL-1α水平显著高于无IFN特征者。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: To determine serum type I IFN (IFN-α2a) concentrations in SSc patients, explore its association with cytokine/chemokine expressions and evaluate correlation with the phenotype including the predictive value for interstitial lung disease (ILD) progression. METHODS: Serum samples were obtained from 200 SSc patients and 29 healthy controls. IFN-α2a levels were measured by ultrasensitive electrochemiluminescence assay. Pro-inflammatory and chemokine panels were determined by Luminex® Discovery Assay multiplex kit. Baseline SSc disease characteristics were recorded together with longitudinal data for determining ILD progression after 2 years. RESULTS: IFN-α2a concentrations were higher in SSc patients compared with controls, although not reaching significance [means ± SD of 49.20 ± 156.8 fg/ml vs 9.606 ± 4.399 fg/ml, respectively (P = 0.158)]. Using the cut-off of 15.9 fg/ml, we identified 62 patients as having a type 1 (T1) IFN signature in their circulation. Patients with an IFN signature had significantly higher levels of chemokines (CCL8, CCL19, CXCL10, CXCL11) and the cytokine IL-1α compared with those without an IFN signature. IFN-α2a concentrations strongly correlated with a T1 IFN-related chemokine score supporting activation of this pathway. Phenotyping association queries revealed association between IFN values and both skin and ILD involvements at baseline. Longitudinal data did not identify IFN as a predictive marker for ILD progression. CONCLUSION: Using serum determinations, the activation of the T1 IFN pathway showed strong correlations with inflammatory mediators and associations with clinical manifestations, especially skin fibrosis and ILD in SSc patients. However, activated IFN pathway was not predictive of ILD progression.
引用
- Gerges E, Cauvet A, Schwarz M, et al. Association of serum interferon alpha-2a levels with disease severity and prognosis in systemic sclerosis. Rheumatology (Oxford). 2025. PMID: 39388243. doi:10.1093/rheumatology/keae546
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。